TEVA · Company research
Teva Pharmaceutical Industries Limited (TEVA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 39.13 | $46,378,650,000 | 42723650000.00 | 37.93938220199477 | — | — | 11.1971632061805891 | 5.9789416011344592 | 102.15561674008810572604 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.